TP53 and Hyperkeratosis: A striking difference in the p53 mutation frequency was found between the carcinoma (30%) and precarcinoma groups (17%) compared with the hyperkeratosis (0%) and common pathological changes (0%) groups (p < 0.05; Table 2).